Immunophotonics
Advertisement
Immunophotonics is at the forefront of interventional immuno-oncology, harnessing a proprietary glycan polymer to stimulate immune responses against cancer and other diseases. Their innovative approach aims to transform routine tumor ablations into effective immunotherapeutic treatments, thereby enhancing modern medicine's capability to combat various forms of cancer.
The company's flagship product, IP-001, not only upregulates T-cell activation but also enhances the efficacy of vaccines, including those targeting infectious diseases like SARS-CoV-2. Immunophotonics is committed to leveraging its technology for the greater benefit of global health, seeking to elevate treatment outcomes across the oncology landscape.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.
Advertisement